Jose Manuel Otero, Chief Operating Officer at Lexeo Therapeutics, Inc. (LXEO), sold 3,016 shares at $6.40 ($19K) on 2026-02-18, disclosed to the SEC on 2026-02-20.
Open-market sale of $19k LXEO by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| LXEO | SELL | 2026-05-20 | $7K | — | Filing → |
| LXEO | SELL | 2026-02-20 | $7K | — | Filing → |
| LXEO | SELL | 2025-11-20 | $7K | — | Filing → |